Conditions: Actinic Keratosis
Keywords: Peplin Actinic keratosis PEP005
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 278
Healthy volunteers: no

Brief summary:
This Phase III study is designed to assess the efficacy and safety of PEP005 Gel, 0.015% when applied to an area of skin containing 4-8 AK lesions on the face or scalp.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: PEP005 (Ingenol Mebutate) gel, 0.015% intervention 2: Vehicle Gel
Intervention descriptions: intervention 1: once daily for 3 consecutive days intervention 2: once daily for 3 consecutive days

Protocol document: